A lethal virus that can inflame and damage the brain has re-emerged in India, reviving fears that a pathogen with a very high death rate could again slip across borders. Health agencies are racing to contain fresh Nipah infections while warning that the conditions that allow this disease to jump from bats to people are not confined to one country.
As governments tighten airport checks and scientists revisit worst case scenarios, the alarm is not about case numbers alone but about what a virus with such a severe form of encephalitis could do if it seeded outbreaks in multiple regions at once.
New Nipah cases in India put the world on notice
The latest warning shot came when the National IHR Focal Point for India notified the World Health Organization of two laboratory confirmed Nipah infections in West Bengal, a reminder that this virus has not disappeared and can resurface with little warning. According to the formal notification, the patients were identified in the state’s eastern corridor, and investigations into their contacts and the precise source of exposure are still underway, underscoring how quickly public health systems must move once Nipah is detected in humans. The alert from the WHO frames these cases as part of a broader pattern of sporadic but serious spillovers from animals to people.
Officials in India are now tracing potential chains of transmission in the affected communities, with teams examining whether the infections stem from direct contact with bats, contaminated food, or human to human spread. The same WHO report notes that the National IHR Focal Point for India relayed details of the two confirmed cases and that field investigations into contacts and the source of exposure are ongoing, a process that can determine whether this is a contained cluster or the start of something larger. That scrutiny is particularly intense in West Bengal, where previous Nipah activity has already primed authorities to respond quickly.
Why experts fear a “brain swelling” virus with up to 75% mortality
What makes Nipah so frightening is not just that it is new to many readers, but that once it infects people it can be devastating. Clinical descriptions highlight a disease that often begins with flu like symptoms and can progress to severe respiratory distress and acute encephalitis, a form of brain inflammation that can leave survivors with long term neurological problems. In some outbreaks, the proportion of patients who die has been extraordinarily high, and health agencies now routinely cite fatality ranges that place Nipah among the most lethal known human viruses.
Recent explainers point out that in January, India reported two Nipah cases and that past outbreaks have shown fatality rates between 40 percent and 75 percent, a span that reflects differences in care and how quickly patients are identified. That upper figure aligns with warnings that a BRAIN SWELLING bat virus has been associated with a 75% mortality rate in some settings, a statistic that helps explain why even a handful of cases can trigger international concern. The combination of encephalitis, respiratory involvement, and such a high potential death rate is why I see Nipah described as a particularly nasty disease in public health briefings and why experts stress the need to understand its full clinical spectrum. These stark numbers are documented in analyses of 40 percent to 75 percent fatality and in travel advisories that highlight the 75% figure.
From bats to humans: how Nipah jumps the species barrier
Nipah is classified as a zoonotic virus, meaning it moves between animals and humans, and its natural reservoir is fruit bats that can shed the pathogen in saliva, urine, and other secretions. In parts of South Asia, those bats feed on date palm sap and orchard fruits, creating opportunities for contamination that can bring the virus into direct contact with people. Health authorities have repeatedly warned that the virus typically spreads from December to May, a period that coincides with bat breeding and sap harvesting seasons, which is why surveillance often intensifies during those months. This seasonal pattern is described in detailed primers on Nipah transmission.
Once the virus crosses into humans, it can spread in several ways, including close contact with infected animals, consumption of contaminated food, and person to person transmission through bodily fluids or respiratory droplets. Public health guidance now emphasizes three major routes of infection, reflecting lessons from the original outbreak in Malaysia and subsequent clusters in Bangladesh and India, where hospital based spread has been a recurring concern. I find that risk framed clearly in overviews that describe how three major ways of exposure can bring the virus into human communities, making it essential to address both environmental and clinical infection control.
Covid style airport checks and global travel warnings
Even with only a small number of confirmed cases, the specter of a virus that can cause brain swelling and kill most of the people it infects has pushed governments to act at borders. Several countries have introduced Covid style screenings at AIRPORTS, including temperature checks and symptom questionnaires for passengers arriving from affected regions, in an effort to spot potential Nipah infections before they can seed local transmission. These measures are part of a broader response that treats Nipah as a candidate for the “Next” pandemic, not because it is spreading widely now but because its characteristics fit the profile of a virus that could cause severe disruption if it gained a foothold in dense urban centers. Reports on Covid era style checks describe how these precautions have been rolled out in response to the cluster in India’s West Bengal state.
Travel advisories have followed, with some health agencies urging caution for trips to parts of India where Nipah has been detected and reminding travelers to avoid contact with bats, pigs, and raw date palm sap. One widely cited warning describes a BRAIN SWELLING bat virus with a 75% mortality rate that could spread globally, language that reflects both the severity of the disease and the reality of modern air travel, where an infected person can cross continents in less time than the virus’s incubation period. I see similar concern in coverage that labels Nipah the “Next” pandemic threat and notes that airports have revived some of the visible screening infrastructure from the Covid years to reassure the public. These themes run through travel alerts that highlight the New warnings and in reports that describe how Nipah is being treated as a nasty disease with pandemic potential.
How governments are preparing for a virus some call the “next pandemic”
Beyond India’s immediate response, other governments are quietly updating their playbooks for dealing with a virus that many experts now rank alongside influenza and coronaviruses in terms of potential global impact. Health authorities in the United Kingdom, for example, have said they are closely monitoring the outbreak of this brain swelling virus and have warned clinicians to watch for flu like symptoms that could signal something more serious. That alert explicitly describes Nipah as a zoonotic virus and notes that some countries have already reintroduced Covid style screenings at airports, a sign that the memory of the last pandemic is shaping how quickly officials move when a new threat appears. These concerns are captured in briefings that describe how Nipah is a now being tracked as a possible “next pandemic” agent.
More from Morning Overview